About Innova Biosciences
Innova Biosciences is a company based in Cambridge (United Kingdom) founded in 2002 was acquired by Abcam in November 2019. Innova Biosciences has raised $196.74 thousand across 3 funding rounds from investors including Abcam and SYGNIS. The company has 1,587 employees as of January 31, 2021. Innova Biosciences operates in a competitive market with competitors including GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
- Headquarter Cambridge, United Kingdom
- Employees 1587 as on 31 Jan, 2021
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Abcam Limited
- Date of Incorporation 12 Feb, 1998
- Jurisdiction CAMBRIDGE, UNITED KINGDOM
-
Annual Revenue
$333.72 M (USD)0as on Dec 31, 2020
-
Net Profit
$16.04 M (USD)0as on Dec 31, 2020
-
EBITDA
Not available
-
Total Equity Funding
$196.74 K (USD)
in 3 rounds
-
Latest Funding Round
$337.28 K (USD), Grant
May 16, 2012
-
Investors
Abcam
& 1 more
-
Employee Count
1587
as on Jan 31, 2021
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Innova Biosciences
Innova Biosciences has successfully raised a total of $196.74K across 3 strategic funding rounds. The most recent funding activity was a Grant round of $337.28 thousand completed in May 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Innova Biosciences
Innova Biosciences has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Abcam and SYGNIS.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Biological reagents and antibodies are developed for life science research.
|
Locked | Locked | Locked | |
|
SYGNIS provides molecular biology reagents for research and laboratory applications.
|
Locked | Locked | Locked |
Investor details for Innova Biosciences
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Innova Biosciences
Investment portfolio details for Innova Biosciences
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Innova Biosciences
Detailed financials for Innova Biosciences
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Innova Biosciences Comparisons
Peer comparison for Innova Biosciences
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Innova Biosciences
Innova Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as GenScript, Sino Biological, Epitomics, Y-Biologics and Mabtech, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Reagents and instruments are provided for life sciences research.
|
|
| Locked | Locked | Locked |
Reagents and kits are provided for clinical research applications.
|
|
| Locked | Locked | Locked |
Monoclonal antibody technology and products are developed by Epitomics.
|
|
| Locked | Locked | Locked |
Developer of antibodies for the treatment of multiple diseases
|
|
| Locked | Locked | Locked |
Antibodies and immunoassay kits are developed for research applications.
|
|
| Locked | Locked | Locked |
Antibody and vaccine culture media products are developed.
|
Detailed competitors of Innova Biosciences
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Innova Biosciences
Complete news archive for Innova Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Innova Biosciences
Innova Biosciences was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Innova Biosciences is headquartered in Cambridge, United Kingdom. It is registered at Cambridge, Cambridgeshire, United Kingdom.
Innova Biosciences is a funded company, having raised a total of $196.74K across 3 funding rounds to date.
As of Jan 31, 2021, the latest employee count at Innova Biosciences is 1,587.
Annual revenue of Innova Biosciences is $333.72M as on Dec 31, 2020.
Innova Biosciences is engaged in the development, manufacturing and marketing of antibody labeling and bioconjugation kits. The company offers a variety of antibody labeling kits (enzyme , fluorescent protein, biotinstreptavidin, tandem, and fluorescent dye tags). In addition, it offers antibody purification kits, gold conjugation kits, immunogen kits, maleimide activated labels, substrates and stabilizers, phosphate detection assays, and affinity resins. On September 19, 2016, the company launched a new product AbPure Magnetic Purification system- the system is based on Protein A Magnetic Beads, with high affinity for IgG molecules thus allowing to purify small quantities of antibody from complex mixtures.
Innova Biosciences's top competitors include Sino Biological, GenScript and Y-Biologics.